EV Biotech Competitors and Similar CompaniesClear all
RECOMBINA's competitors and similar companies include ReCode Therapeutics and Spotlight Therapeutics.
 RECOMBINA RECOMBINA is a biotechnological company that offers customized genetic engineering services. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Spotlight Therapeutics Spotlight Therapeutics is a biotechnology company that develops therapeutics by enabling direct in vivo gene editing. | |
Founding Date | Founding Date 2013 | Founding Date 2015 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Pamplona, ES HQ | Locations Menlo Park, US HQ | Locations Hayward, US HQ |
Employees | Employees 614% decrease | Employees 1062% decrease | Employees 1914% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 80m (about 6 years ago) | Latest funding round $ 6.9m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 82m | Total funding raised $ 14.2m |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companySpotlight Therapeutics
HQ
Hayward, US
Employees
19↓ 14% decrease
Spotlight Therapeutics is a biotechnology company that develops therapeutics by enabling direct in vivo gene editing.
View company